Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Single-Blind, Active Comparator-controlled Study to Evaluate the Safety and Immunological Efficacy of GC3114 in Healthy Adults.

NCT03357263 is registered in ClinicalTrials.gov with Green Cross Corporation as lead sponsor.

NCT NCT03357263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03357263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Single-Blind, Active Comparator-controlled Study to Evaluate the Safety and Immunological Efficacy of GC3114 in Healthy Adults.
Lead sponsor
Green Cross Corporation
Phase
Phase 1
Overall status
Completed
Start date
November 20, 2017
Completion date
December 22, 2017
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, human